Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Allopatch
- Development stage
- Unknown
- Lead developer
- MTF Biologics
- Administration
- Topical, Surgical Implantation
01
Overview
Allopatch is an acellular human dermal matrix (ADM) derived from donated human cadaveric skin, processed to remove cellular components while preserving the native extracellular matrix (ECM) architecture. Developed by the Musculoskeletal Transplant Foundation (MTF Biologics), it serves as a biological scaffold that facilitates host cell infiltration, revascularization, and tissue remodeling. The product is available in different forms, including a high-density (HD) version and a pliable reticular layer version, each optimized for specific structural and biological requirements. Allopatch is primarily utilized in orthopedic surgery for the augmentation and bridging reconstruction of large to massive rotator cuff tears and chronic Achilles tendon ruptures, as well as in wound management for the treatment of chronic diabetic foot ulcers (DFUs).
- Brand names
- AllopatchAlloPatch HDAlloPatch Pliable
- Other names
- Acellular human dermal matrixADMHuman reticular acellular dermal matrixDecellularized dermis allograft
Beyond the preview
Go deeper on Allopatch.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Allopatch.